BMP4 and glioblastoma: Transient ex vivo delivery of BMP4 was shown to potently inhibit the ability of human-derived GBM cells to successfully initiate tumor formation following intracerebral transplantation, while in vivo delivery of BMP4 effectively blocked tumor growth and reduced associated mortality following intracerebral grafting (Piccirillo and Vescovi, 2006).